|
1
|
Liebner DA and Shah MH: Thyroid cancer:
Pathogenesis and targeted therapy. Ther Adv Endocrinol Metab.
2:173–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pellegriti G, Frasca F, Regalbuto C,
Squatrito S and Vigneri R: Worldwide increasing incidence of
thyroid cancer: Update on epidemiology and risk factors. J Cancer
Epidemiol. 2013:9652122013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahn HS, Kim HJ and Welch HG: Korea's
thyroid-cancer ‘Epidemic’-screening and overdiagnosis. N Engl J
Med. 371:1765–1767. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Colonna M, Uhry Z, Guizard AV, Delafosse
P, Schvartz C, Belot A and Grosclaude P; FRANCIM network, : Recent
trends in incidence, geographical distribution, and survival of
papillary thyroid cancer in France. Cancer Epidemiol. 39:511–518.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rhee YH, Moon JH, Choi SH and Ahn JC:
Low-level laser therapy promoted aggressive proliferation and
angiogenesis through decreasing of transforming growth factor-β1
and increasing of Akt/Hypoxia inducible factor-1α in anaplastic
thyroid cancer. Photomed Laser Surg. 34:229–235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Callender GG, Carling T, Christison-Lagay
E and Udelsman R: Surgery for thyroid cancer. Curr Opin Endocrinol
Diabetes Obess. 43:443–458. 2014.
|
|
8
|
Sipos J and Mazzaferri E: Thyroid cancer
epidemiology and prognostic variables. Clin Oncol. 22:395–404.
2010. View Article : Google Scholar
|
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y and Tang L: The application of
lncRNAs in cancer treatment and diagnosis. Recent Pat Anticancer
Drug Discov. 13:292–301. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ignarski M, Islam R and Müller RU: Long
non-coding RNAs in kidney disease. Int J Mol Sci. 20:32762019.
View Article : Google Scholar
|
|
12
|
Xu YZ, Chen FF, Zhang Y, Zhao QF, Guan XL,
Wang HY, Li A, Lv X, Song SS, Zhou Y and Li XJ: The long noncoding
RNA FOXCUT promotes proliferation and migration by targeting FOXC1
in nasopharyngeal carcinoma. Tumour Biol. 39:10104283177060542017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li HJ, Li X, Pang H, Pan JJ, Xie XJ and
Chen W: Long non-coding RNA UCA1 promotes glutamine metabolism by
targeting miR-16 in human bladder cancer. Jpn J Clin Oncol.
45:1055–1063. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang X, Yin R, Shi H, Wang X, Shen D, Wang
X and Pan C: lncRNA ZFAS1 confers inflammatory responses and
reduces cholesterol efflux in atherosclerosis through regulating
miR-654-3p-ADAM10/RAB22A axis. Int J Cardiol. 315:72–80. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou HL, Zhou YF and Feng ZT: Long
noncoding RNA ZFAS1 promotes hepatocellular carcinoma proliferation
by epigenetically repressing miR-193a-3p. Eur Rev Med Pharmacol
Scis. 23:9840–9847. 2019.
|
|
17
|
Zhang J, Quan LN, Meng Q, Wang HY, Wang J,
Yu P, Fu JT, Li YJ, Chen J, Cheng H, et al: miR-548e sponged by
ZFAS1 regulates metastasis and cisplatin resistance of OC by
targeting CXCR4 and let-7a/BCL-XL/S signaling axis. Mol Ther
Nucleic Acids. 20:621–638. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang S, Wang J, Yao T and Tao M: lncRNA
ZFAS1/miR-589 regulates the PTEN/PI3K/AKT signal pathway in the
proliferation, invasion and migration of breast cancer cells.
Cytotechnology. 72:415–425. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan J, Xu X and Wang G: lncRNA ZFAS1 is
involved in the proliferation, invasion and metastasis of prostate
cancer cells through competitively binding to miR-135a-5p. Cancer
Manage Res. 12:1135–1149. 2020. View Article : Google Scholar
|
|
20
|
Han CG, Huang Y and Qin L: Long non-coding
RNA ZFAS1 as a novel potential biomarker for predicting the
prognosis of thyroid Cancer. Med Sci Monit. 25:2984–2992. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tong H, Zhuang X, Cai J, Ding Y, Si Y,
Zhang H and Shen M: Long noncoding RNA ZFAS1 promotes progression
of papillary thyroid carcinoma by sponging miR-590-3p and
upregulating HMGA2 expression. Onco Targets Ther. 12:7501–7512.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tam C, Wong JH, Tsui SKW, Zuo T, Chan TF
and Ng TB: lncRNAs with miRNAs in regulation of gastric, liver, and
colorectal cancers: Updates in recent years. App Microbiol
Biotechnol. 103:4649–4677. 2019. View Article : Google Scholar
|
|
23
|
Ye Y, Song Y, Zhuang J, Wang G, Ni J,
Zhang S and Xia W: MicroRNA-302a-3p suppresses hepatocellular
carcinoma progression by inhibiting proliferation and invasion.
Onco Targets Ther. 11:8175–8184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo Z, Yi ZJ, Ou ZL, Han T, Wan T, Tang
YC, Wang ZC and Huang FZ: RELA/NEAT1/miR-302a-3p/RELA feedback loop
modulates pancreatic ductal adenocarcinoma cell proliferation and
migration. J Cell Physiol. 234:3583–3597. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pan X, Li D, Huo J, Kong F, Yang H and Ma
X: LINC01016 promotes the malignant phenotype of endometrial cancer
cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis.
Cell Death Dis. 9:3032018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao M, Sano D, Pickering CR, Jasser SA,
Henderson YC, Clayman GL, Sturgis EM, Ow TJ, Lotan R, Carey TE, et
al: Assembly and initial characterization of a panel of 85
genomically validated cell lines from diverse head and neck tumor
sites. Clin Cancer Res. 17:7248–7264. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Henderson YC, Ahn SH, Ryu J, Chen Y,
Williams MD, El-Naggar AK, Gagea M, Schweppe RE, Haugen BR, Lai SY
and Clayman GL: Development and characterization of six new human
papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab.
100:E243–E252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dutil J, Chen Z, Monteiro AN, Teer JK and
Eschrich SA: An interactive resource to probe genetic diversity and
estimated ancestry in cancer cell lines. Cancer Res. 79:1263–1273.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fabien N, Fusco A, Santoro M, Barbier Y,
Dubois PM and Paulin C: Description of a human papillary thyroid
carcinoma cell line. Morphologic study and expression of tumoral
markers. Cancer. 73:2206–2212. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schweppe RE, Klopper JP, Korch C,
Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland
JA, Smallridge RC and Haugen BR: Deoxyribonucleic acid profiling
analysis of 40 human thyroid cancer cell lines reveals
cross-contamination resulting in cell line redundancy and
misidentification. J Clin Endocrinol Metab. 93:4331–4341. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dong D, Mu Z, Wei N, Sun M, Wang W, Xin N,
Shao Y and Zhao C: Long non-coding RNA ZFAS1 promotes proliferation
and metastasis of clear cell renal cell carcinoma via targeting
miR-10a/SKA1 pathway. Biomed Pharmacother. 111:917–925. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie S, Ge Q, Wang X, Sun X and Kang Y:
Long non-coding RNA ZFAS1 sponges miR-484 to promote cell
proliferation and invasion in colorectal cancer. Cell Cycle.
17:154–161. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kapoor C, Vaidya S, Wadhwan V, Kaur G and
Pathak A: Seesaw of matrix metalloproteinases (MMPs). J Cancer Res
Ther. 12:28–35. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Itoh Y: Metalloproteinases in rheumatoid
arthritis: Potential therapeutic targets to improve current
therapies. Progress in Molecular Biology and Translational Science.
Elsevier; pp. 327–338. 2017, View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gheissari A, Meamar R, Abedini A,
Roomizadeh P, Shafiei M, Samaninobandegani Z, Tabrizi Z, Mahmoudi
F, Merrikhi A and Najafi Tavana E: Association of matrix
metalloproteinase-2 and matrix metalloproteinase-9 with endothelial
dysfunction, cardiovascular disease risk factors and thrombotic
events in children with end-stage renal disease. Iran J kidney Dis.
12:169–177. 2018.PubMed/NCBI
|
|
37
|
Balistreri CR, Allegra A, Crapanzano F,
Pisano C and Ruvolo G: Matrix metalloproteinases (MMPs), their
genetic variants and miRNA in mitral valve diseases: Potential
biomarker tools and targets for personalized treatments. J Heart
Valve Dis. 25:463–474. 2016.PubMed/NCBI
|
|
38
|
Li F, Jin D, Guan L, Zhang CC, Wu T, Wang
YJ and Gao DS: CEP55 promoted the migration, invasion and
neuroshpere formation of the glioma cell line U251. Neurosci Lett.
705:80–86. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheng D, Jiang S, Chen J, Li J, Ao L and
Zhang Y: The increased lncRNA MIR503HG in preeclampsia modulated
trophoblast cell proliferation, invasion, and migration via
regulating matrix metalloproteinases and NF-κB signaling. Dis
Markers. 2019:49768452019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang X, Yang B, She Y and Ye Y: The lncRNA
TP73-AS1 promotes ovarian cancer cell proliferation and metastasis
via modulation of MMP2 and MMP9. J Cell Biochem. 119:7790–7799.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Frismantiene A, Philippova M, Erne P and
Resink TJ: Cadherins in vascular smooth muscle cell (patho)biology:
Quid nos scimus? Cell Sign. 45:23–42. 2018. View Article : Google Scholar
|
|
43
|
Abdallah RA, Abdou AG, Abdelwahed M and
Ali H: Immunohistochemical expression of E- and N-Cadherin in
nodular prostatic hyperplasia and prostatic carcinoma. J Microsc
Ultrastruct. 7:19–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Oystese KAB, Berg JP, Normann KR, Zucknick
M, Casar-Borota O and Bollerslev J: The role of E and N-cadherin in
the postoperative course of gonadotroph pituitary tumours.
Endocrine. 62:351–360. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Z, Li J, Guo H, Wang F, Ma L, Du C,
Wang Y, Wang Q, Kornmann M, Tian X and Yang Y: BRM
transcriptionally regulates miR-302a-3p to target SOCS5/STAT3
signaling axis to potentiate pancreatic cancer metastasis. Cancer
Lett. 449:215–225. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li X, Huo X, Li W, Yang Q, Wang Y and Kang
X: Genetic association between cyclin D1 polymorphism and breast
cancer susceptibility. Tumour Biol. 35:11959–11965. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Neumeister P, Pixley FJ, Xiong Y, Xie H,
Wu K, Ashton A, Cammer M, Chan A, Symons M, Stanley ER and Pestell
RG: Cyclin D1 governs adhesion and motility of macrophages. Mol
Biol Cell. 14:2005–2015. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhong Z, Yeow WS, Zou C, Wassell R, Wang
C, Pestell RG, Quong JN and Quong AA: Cyclin D1/cyclin-dependent
kinase 4 interacts with filamin A and affects the migration and
invasion potential of breast cancer cells. Cancer Res.
70:2105–2114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ullah Shah A, Mahjabeen I and Kayani MA:
Genetic polymorphisms in cell cycle regulatory genes CCND1 and CDK4
are associated with susceptibility to breast cancer. J BUON.
20:985–993. 2015.PubMed/NCBI
|
|
51
|
Guo F, Fu Q, Wang Y and Sui G: Long
non-coding RNA NR2F1-AS1 promoted proliferation and migration yet
suppressed apoptosis of thyroid cancer cells through regulating
miRNA-338-3p/CCND1 axis. J Cell Mol Med. 23:5907–5919. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jeon S, Kim Y, Jeong YM, Bae JS and Jung
CK: CCND1 splice variant as a novel diagnostic and predictive
biomarker for thyroid cancer. Cancers (Basel). 10:4372018.
View Article : Google Scholar
|
